Cytotoxic drugs for gastric and colorectal cancer.

This publication has 13 references indexed in Scilit:

• A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study.
  Journal of Clinical Oncology, 1989
• A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma.
  Journal of Clinical Oncology, 1988
• A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma.
  Journal of Clinical Oncology, 1987
• Evaluation of the prognostic factors in gastric cancer: The effect of chemotherapy on survival
  British Journal of Surgery, 1987
• PREVENTION OF EMESIS IN PATIENTS RECEIVING CYTOTOXIC DRUGS BY GR38032F, A SELECTIVE 5-HT3 RECEPTOR ANTAGONIST
  The Lancet, 1987
• Cis-platinum as second-line chemotherapy in advanced gastric adenocarcinoma. A phase II study of the EORTC gastrointestinal tract cancer cooperative group
  European Journal of Cancer and Clinical Oncology, 1985
• Phase II trial of 5-fluorouracil, adriamycin and cisplatin (FAP) in advanced gastric cancer
  Cancer Chemotherapy and Pharmacology, 1985
• A Comparison of Three Chemotherapeutic Regimens in the Treatment of Advanced Pancreatic and Gastric Carcinoma
  JAMA, 1985
• Advanced gastric cancer: Experience in Scotland using 5-fluorouracil, adriamycin and mitomycin-C
  British Journal of Surgery, 1984
• A phase II study of cisplatin in advanced gastric cancer
  European Journal of Cancer and Clinical Oncology, 1983